Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen, Sjaak A Burgers, Paul Baas, Dick Pluim, Matthijs Tibben, Erik van Werkhoven, Enzo Alessio, Gianni Sava, Jos H Beijnen, Jan H M Schellens
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy'. Together they form a unique fingerprint.